SMARCB1 and schwannomatosis: By contrast, mitotic recombination accounts for 19% of the LOH events in NF2-associated schwannomas (14 of 72 schwannomas analysed) and 23% (5/22) of schwannomas from schwannomatosis patients without germline SMARCB1 mutations (Hadfield et al. 2010a).